YHB Investment Advisors Inc. Makes New $2.17 Million Investment in Invesco Biotechnology & Genome ETF $PBE

YHB Investment Advisors Inc. purchased a new stake in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 22,296 shares of the company’s stock, valued at approximately $2,169,000. YHB Investment Advisors Inc. owned about 0.51% of Invesco Biotechnology & Genome ETF at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Envestnet Asset Management Inc. lifted its position in shares of Invesco Biotechnology & Genome ETF by 4.2% in the second quarter. Envestnet Asset Management Inc. now owns 22,250 shares of the company’s stock valued at $1,995,000 after acquiring an additional 888 shares in the last quarter. Archford Capital Strategies LLC lifted its holdings in Invesco Biotechnology & Genome ETF by 6.7% in the 2nd quarter. Archford Capital Strategies LLC now owns 6,252 shares of the company’s stock valued at $560,000 after purchasing an additional 395 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new position in Invesco Biotechnology & Genome ETF in the 2nd quarter valued at about $84,000. Compass Financial Management LLC acquired a new stake in shares of Invesco Biotechnology & Genome ETF during the 2nd quarter worth about $27,000. Finally, Dynamic Advisor Solutions LLC purchased a new stake in shares of Invesco Biotechnology & Genome ETF during the second quarter worth about $484,000.

Invesco Biotechnology & Genome ETF Stock Down 0.8%

Shares of PBE traded down $0.73 on Thursday, hitting $94.10. 5,991 shares of the stock traded hands, compared to its average volume of 13,848. The firm has a market capitalization of $411.22 million, a P/E ratio of 20.44 and a beta of 0.70. The stock’s 50 day moving average is $95.29 and its two-hundred day moving average is $87.91. Invesco Biotechnology & Genome ETF has a 1 year low of $70.01 and a 1 year high of $98.82.

Invesco Biotechnology & Genome ETF Profile

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies. The Fund will normally invest at least 90% of its total assets in common stocks that consists of the Index. The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.